Aeras appointed Jacqueline E. Shea PhD as Chief Operating Officer (COO). In the newly established role of COO, Dr. Shea joins Aeras’s senior leadership team “to advance organizational excellence and drive innovation and growth of our core capacities, including our contract manufacturing operations.” Shea was most recently Vice President of Business Development Europe for Emergent BioSolutions. “We are fortunate to have Jacqui Shea join Aeras as its operational model evolves to tackle the challenges of TB vaccine research and development,” said Tom Evans, MD, Aeras’s President and Chief Executive Officer.
Full media release: April 4, 2014 – http://www.aeras.org/pressreleases/jacqui-shea-appointed-chief-operating-officer-at-aeras#.U0BmtVcWNdc